Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Mohammed Ahmed

Mastercard Foundation scholar


MSc by Research in Oncology, Corpus Christi College

Sudan

Mohammed Ahmed is a medical doctor who graduated from the University of Medical Sciences and Technology in Khartoum, Sudan. Mohammed is studying for an MSc by Research in Oncology as a Mastercard Foundation AfOx scholar at Corpus Christi College, University of Oxford. 

Before joining Oxford, he worked as a teaching assistant at the University of Medical Sciences and Technology. He also practised as a physician in a neurology clinic for over three years, managing many patients with diverse conditions. He also led and participated in various research projects focusing on neurological disorders. Throughout his experience, he became acutely aware of the significant lack of individualised treatment options and sought to improve his knowledge in this field to help deliver better, patient-tailored care.

To further his expertise in precision medicine, he enrolled in a master's program in Medical Genetics and Genomics at the University of Glasgow. He is particularly interested in cancer and especially the application of personalised models in cancer treatment. 

After graduation, Mohammed plans to pursue a Ph.D. and launch his career in cancer sciences. He aspires to work in a research setting designing unified models that compile clinical data from cancer patients and data from the various -omics fields, including but not limited to metabolomics, genomics, proteomics, microbiomics, and exposomics. Mohammed is also eager to collect cancer data from understudied African patients to help create African biologic databases that provide data for cancer diagnosis management and further research.